Back

The assessment of the selenium supplementation on hashimoto's thyroiditis, systematic review and Meta-Analysis

alijani, e.

2020-04-20 endocrinology
10.1101/2020.04.15.20066001
Show abstract

BackgroundSelenium forms a significant component of seleno-proteins in the body. Seleno-methionine is integrated into proteins instead of methionine and acts as a storage pool. In proteins, the active form of Selenium is seleno-cysteine.in this review we aim to prevail the results of selenium effect on thyroid status in recent clinical trials. The systemic review aims to find out the correlation between supplementation of Selenium and anti-TPO antibodies and T4 levels in Hashimotos Thyroiditis. Selenium supplementation decreases the level of anti-TPO antibodies. The supplementation of Selenium increases the level of T4 levels. MethodsThe mean and standard deviation (SD) of all 8 studies was were calculated. One of the researches had all the information in figures, and only the levels of anti-TPO antibodies and FT4 were obtained. Heterogenicity was estimated using I2. ResultsThe p-value calculated for Anti-TPO by SPSS of the eight groups had a p-value of 0.142. The p-value calculated for T4 levels by SPSS of the five groups had a p-value of 0.239. The heterogenicity test was zero after the I2 test. The studies that were included in the systematic review were assessed by Prisma diagram and selected among the articles resulted from search keywords selenium and anti tpo and hashimotho thyroiditis on different data sources. All the participants were evaluated by sex, ages, duration of the study and the levels of anti tpo ab and thyroxin (t4) and then using SPSS software to deploy metanalysis in the systematic review. Conclusionin 6 of 8 studies it was a relation of selenium and thyroid status, whereas 2 studies were not. As We ran meta analysis on the data we realized that there is not significant desired effect from selenium on thyroid antibodies against previous metanalysis done by other researchers.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
The Journal of Clinical Endocrinology & Metabolism
based on 26 papers
Top 0.8%
10.5%
2
PLOS ONE
based on 1737 papers
Top 49%
10.5%
3
JMIR Research Protocols
based on 18 papers
Top 0.2%
5.5%
4
Frontiers in Endocrinology
based on 20 papers
Top 0.7%
5.5%
5
Scientific Reports
based on 701 papers
Top 35%
5.2%
6
Contemporary Clinical Trials Communications
based on 11 papers
Top 0.1%
3.0%
7
Nutrients
based on 43 papers
Top 1%
3.0%
8
Journal of Clinical Medicine
based on 77 papers
Top 6%
2.5%
9
Heliyon
based on 57 papers
Top 3%
2.5%
10
Cureus
based on 64 papers
Top 9%
1.9%
50% of probability mass above
11
Journal of Affective Disorders
based on 72 papers
Top 4%
1.8%
12
International Journal of Environmental Research and Public Health
based on 116 papers
Top 12%
1.8%
13
PLOS Global Public Health
based on 287 papers
Top 14%
1.8%
14
Informatics in Medicine Unlocked
based on 11 papers
Top 1%
1.6%
15
Biology
based on 11 papers
Top 0.3%
1.6%
16
COVID
based on 12 papers
Top 0.1%
1.6%
17
PeerJ
based on 46 papers
Top 6%
1.4%
18
eLife
based on 262 papers
Top 21%
1.4%
19
Schizophrenia
based on 13 papers
Top 0.8%
1.4%
20
BMC Public Health
based on 148 papers
Top 17%
1.4%
21
Journal of Psychosomatic Research
based on 10 papers
Top 0.4%
1.4%
22
JMIRx Med
based on 29 papers
Top 3%
1.4%
23
Frontiers in Public Health
based on 135 papers
Top 19%
1.4%
24
JMIR Public Health and Surveillance
based on 45 papers
Top 8%
1.3%
25
BMJ Open Diabetes Research & Care
based on 14 papers
Top 1%
1.2%
26
BMJ Open
based on 553 papers
Top 46%
1.2%
27
Medicine
based on 29 papers
Top 7%
0.8%
28
BMC Medicine
based on 155 papers
Top 21%
0.8%
29
European Respiratory Journal
based on 44 papers
Top 5%
0.8%
30
Metabolites
based on 10 papers
Top 1.0%
0.8%